BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Biocept, Inc. 

2151 Las Palmas Drive, Suite C

Carlsbad  California  92009  U.S.A.
Phone: 760-804-9580 Fax: 760-804-6238


SEARCH JOBS




Industry
Biotechnology






 Company News
Biocept, Inc. (BIOC) Appoints Commercialization Leader To Implement Global Diagnostic Sales Program 3/25/2014 9:08:17 AM    More...
Biocept, Inc. (BIOC) To Present At The 26th Annual ROTH Conference 3/5/2014 9:24:36 AM    More...
Biocept, Inc. (BIOC) Announces Closing Of Initial Public Offering 2/11/2014 9:25:18 AM    More...
Biocept, Inc. (BIOC) Goes Public At $10, The Low End Of The Range 2/5/2014 9:43:10 AM    More...
Biocept, Inc. Sets Price Range on Proposed IPO; Anticipates $17.7 Million in Net Proceeds 11/7/2013 7:50:09 AM    More...
Biocept, Inc. Appoints Michael Nall as CEO 9/11/2013 7:04:55 AM    More...
MD Anderson Cancer Center and Biocept, Inc. Study Reveals HER2+ CTCs and DTCs in Patients With HER2- Tumors by Tissue Analysis 6/4/2013 11:17:26 AM    More...
Biocept, Inc. to Present at the American Association for Cancer Research Annual Meeting on Ability of its CEE-SelectorTM Technology to Enhance the Sensitivity of Sequencing for Rare Mutation Detection 4/5/2013 6:30:37 AM    More...
Biocept, Inc. to Present at the 103rd American Association for Cancer Research Annual Meeting on New Analytic Methods for Circulating Tumor Cell Analysis, Including SelectorTM, Ultra-Sensitive Mutation Detection Technology 4/2/2012 10:35:47 AM    More...
Biocept, Inc. to Present at the Molecular Medicine Tri-Conference on Circulating Tumor Cell (CTC) Technologies 2/22/2012 6:46:49 AM    More...
1234